Designing novel multifunctional nanosystems to improve intracellular delivery
Designing novel multifunctional nanosystems to improve intracellular delivery
批准号:
RGPIN-2022-04398
负责人:
Gadde, Suresh
金额:
$2.11万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The growing interest in applying nanotechnology to medicine, nanomedicine, is due to its appealing features in drug delivery, diagnosis, and imaging. Nanotechnology-based drug delivery platforms (nanoparticles, NPs) are typically in 1-100 nm range, capable of encapsulating thousands of therapeutic and/or imaging agents inside their nanostructures and delivering them directly to the disease sites, enhancing their therapeutic effects and minimizing unwanted toxicities. Despite significant enthusiasm and investment, the field has not yet reached its full potential, as only ~17 nanomedicines have been approved for clinical use in Europe and North America. Several issues, such as optimizing the biophysiochemical properties of NPs, gaining the fundamental understanding of nano-bio interactions, and improving the intracellular delivery of therapeutic agents, need to be addressed to maximize the potential of nanotechnology applications in healthcare. The long-term vision of our research program is to develop a fundamental framework for rationally designing and developing NPs for site-specific delivery, overcoming a variety of biological barriers to reach desired sites, identifying optimal NP dose ranges to achieve maximum effect, and minimizing adverse effects induced by the nanomaterials themselves. To this end, my research program is centred around two main interconnected themes: the design and synthesis of advanced multifunctional NP platforms for improved intracellular delivery of a variety of agents; and the exploration of their interactions with blood, tissue, cellular and intracellular components in vitro and in vivo settings. The short-term objective of the proposed research program is to gain a detailed understanding of nano-bio interactions of redox-responsive NPs with intracellular components in the context of NPs' intracellular trafficking and payload delivery. Our aims are 1) Develop novel redox-responsive NPs for nucleotides delivery. 2) Study the impact of NP's interactions with endosomal-lysosomal components on intracellular trafficking and delivery in biological settings. The long-term goal is to incorporate the knowledge gained from these studies into a feedback loop to develop next-generation NPs. The outcome of my research program will provide guidelines for rationally designing potent nanoparticle-based drug delivery systems and thus advancing the nanomedicine research field. Most importantly, highly qualified personnel trained in this research program will learn various experimental and analytical skills in chemistry, engineering, and biology. Additionally, they will also benefit from a robust interdisciplinary environment and gain valuable research experience equipping them for careers in both industry and academia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designing novel multifunctional nanosystems to improve intracellular delivery
-
批准号:DGECR-2022-00065
-
项目类别:Discovery Launch Supplement
-
资助金额:$0.91万
-
财政年份:2022
-
负责人:Gadde, Suresh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: